New breed of drugs offers hope in cancer war Specialists, pharma firms optimistic about new targeted treatments |
 | INTERACTIVE |
 |
 | INTERACTIVES AND QUIZZES |
 | Free video |
 | Cancer innovations ImClone's Erbitux, which has shown a survival benefit for head and neck cancer patients, stole the show at the American Society of Clinical Oncology meeting in New Orleans this week, CNBC's Mike Huckman reports. CNBC |
SPECIAL REPORT: CANCER TREATMENTS |
Are we winning the war on cancer? The best medicine has to offer still isn't enough to help all cancer patients. But armed with new knowledge, doctors predict they'll be saving many more lives in the next few decades. |
Sponsored links
Resource guide
Hotmail